These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35874985)

  • 1. Queueing Theory and COVID-19 Prevention: Model Proposal to Maximize Safety and Performance of Vaccination Sites.
    Di Pumpo M; Ianni A; Miccoli GA; Di Mattia A; Gualandi R; Pascucci D; Ricciardi W; Damiani G; Sommella L; Laurenti P
    Front Public Health; 2022; 10():840677. PubMed ID: 35874985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A queueing Network approach for capacity planning and patient Scheduling: A case study for the COVID-19 vaccination process in Colombia.
    Franco C; Herazo-Padilla N; Castañeda JA
    Vaccine; 2022 Nov; 40(49):7073-7086. PubMed ID: 36404425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
    Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model.
    Pople D; Monk EJM; Evans S; Foulkes S; Islam J; Wellington E; Atti A; Hope R; Robotham J; Hopkins S; Brown CS; Hall VJ;
    BMJ; 2022 Jul; 378():e070379. PubMed ID: 35858689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Littlecott H; Krishnaratne S; Burns J; Rehfuess E; Sell K; Klinger C; Strahwald B; Movsisyan A; Metzendorf MI; Schoenweger P; Voss S; Coenen M; Müller-Eberstein R; Pfadenhauer LM
    Cochrane Database Syst Rev; 2024 May; 5(5):CD015029. PubMed ID: 38695826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cross-sectional Survey of Public Knowledge and Perspective on Coronavirus Disease, Vaccination, and Related Research in India during the COVID-19 Pandemic.
    Munshi R; Maurya M
    J Assoc Physicians India; 2023 Sep; 71(9):19-27. PubMed ID: 38700297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
    Sandmann FG; Davies NG; Vassall A; Edmunds WJ; Jit M;
    Lancet Infect Dis; 2021 Jul; 21(7):962-974. PubMed ID: 33743846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing Mass Vaccination Programs with Queueing Theory and Spatial Optimization.
    Xie S; Rieders M; Changolkar S; Bhattacharya BB; Diaz EW; Levy MZ; Castillo-Neyra R
    medRxiv; 2024 Jul; ():. PubMed ID: 38947058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass production methods for mass vaccination: improving flow and operational performance in a COVID-19 mass vaccination centre using Lean.
    Smith IM; Smith DTL
    BMJ Open Qual; 2021 Sep; 10(3):. PubMed ID: 34518300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Immunity in the Cohort of IRCCS San Raffaele Hospital Employees after BNT162b2 Vaccination: A Retrospective Observational Study.
    Stocchi M; Melodia P; Lucini A; De Lorenzo R; Pozzi C; Rovere-Querini P; Odone A; Renzi C; Signorelli C
    Ann Ig; 2024; 36(4):432-445. PubMed ID: 38386027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
    Constantin AM; Noertjojo K; Sommer I; Pizarro AB; Persad E; Durao S; Nussbaumer-Streit B; McElvenny DM; Rhodes S; Martin C; Sampson O; Jørgensen KJ; Bruschettini M
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD015112. PubMed ID: 38597249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination Setting of Patients with Autoimmune Diseases in Times of Severe Acute Respiratory Syndrome Coronavirus Type 2 Pandemic Using the Example of Multiple Sclerosis Patients: A Longitudinal Multicenter Study.
    Heidler F; Baldt J; Frahm N; Langhorst SE; Mashhadiakbar P; Streckenbach B; Zettl UK; Richter J
    Eur Neurol; 2022; 85(2):104-111. PubMed ID: 34743082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 infection after COVID-19 immunization in healthcare workers: A retrospective, pilot study.
    Vaishya R; Sibal A; Malani A; Prasad KH
    Indian J Med Res; 2021 May&Jun; 153(5&6):550-554. PubMed ID: 34341227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines alone will not prevent COVID-19 outbreaks among migrant workers-the example of meat processing plants.
    Fabreau GE; Holdbrook L; Peters CE; Ronksley PE; Attaran A; McBrien K; Pottie K
    Clin Microbiol Infect; 2022 Jun; 28(6):773-778. PubMed ID: 35189335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and vaccination: myths vs science.
    Chavda VP; Chen Y; Dave J; Chen ZS; Chauhan SC; Yallapu MM; Uversky VN; Bezbaruah R; Patel S; Apostolopoulos V
    Expert Rev Vaccines; 2022 Nov; 21(11):1603-1620. PubMed ID: 35980281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis.
    Marcellusi A; Fabiano G; Sciattella P; Andreoni M; Mennini FS
    Clin Drug Investig; 2022 Mar; 42(3):237-242. PubMed ID: 35218000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.